ALYSSA FREY: Open Payments
NPI 1801356027 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 34 payments from 16 companies in 2025. Trend: 2023 $740 · 2024 $788 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $250 |
| Mannkind Corporation | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Dexcom, Inc. | 1 | $44 |
| PFIZER INC. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Averitas Pharma Inc. | 1 | $27 |
| BETA BIONICS, INC. | 1 | $25 |
| Medtronic, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
Products named: Rybelsus, AFREZZA, Ozempic, REXULTI, Wegovy, DEXCOM G7 GSS (161), CAPLYTA, QUTENZA.
Industry payments across GA — which companies pay providers there.
